SEC Form 4 · accession 0000899243-18-006756
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Renee D Gala
Director
Period of report
Mar 6, 2018
Accepted (ET)
Mar 7, 2018 · 8:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 6, 2018 | P | 1,000 | $15.30 | A | 1,000 | D | |
| Common StockF1 | Mar 7, 2018 | P | 9,000 | $15.5335 | A | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average purchase price for the entire number of shares purchased. The actual purchase prices range from $15.5334 to $15.5399 per share. Detailed information on the exact number of shares purchased at each purchase price can be obtained from the issuer upon request.